BP vs NESR

BP's Advanced Deterministic Scorecard shows a Piotroski F-Score of 6/9, indicating stable financial health, but the absence of an Altman Z-Score limits distress risk assessment. The stock trades at a significant premium to its Graham Number ($7.35) and even the growth-based intrinsic value ($18.88), currently priced at $36.53, driven by high forward earnings expectations. While profitability metrics and dividend yield are attractive, elevated valuation multiples, inconsistent earnings surprises, and a dangerously high payout ratio of 315% raise sustainability concerns. Analysts recommend a 'buy' with a target of $38.73, supported by strong insider sentiment, though no insider transactions have occurred recently.

NESR exhibits strong operational health with a Piotroski F-Score of 7/9, though it lacks an Altman Z-Score for bankruptcy risk assessment. While the company shows impressive price momentum and a low Forward P/E of 9.72, the current price of $23.25 trades at a massive premium compared to its Graham Number ($10.60) and Intrinsic Value ($3.64). The disconnect between deterministic value and market price suggests the stock is priced for aggressive future growth rather than current fundamentals. Overall, the strong balance sheet and revenue growth are offset by extreme valuation stretching.